Geron (GERN) Raw Materials (2024)
Geron (GERN) posted Raw Materials of $4.9 million for Q4 2024, down 16.47% sequentially from $5.9 million in Q3 2024.
Geron (GERN) Raw Materials (2024) Analysis & Trends
Geron has reported Raw Materials for 1 years, with the latest figure at $4.9 million in Q4 2024.
- Quarterly Raw Materials changed N/A year-over-year to $4.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $4.9 million (changed N/A YoY) and the FY2024 annual result came in at $4.9 million, changed N/A from the prior year.
- Raw Materials declined to $4.9 million in Q4 2024 per GERN's latest filing, from $5.9 million in the prior quarter.
- Over five years, Raw Materials peaked at $5.9 million in Q3 2024 and troughed at $4.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - |
| 10 | Geron | 1.05 Mn | -299.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 5.87 Mn |